3646 results for «538»
3646 results
Featured Research - Aortic valve (Part 5)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of research abstracts from PCR London Valves 2024, covering a wide range of topics related to aortic valve interventions. Explore insights on predicting pacemaker need after TAVI, the impact of commissural misalignment and leaflet laceration, long-term outcomes with different valve types,...
Featured cases - TAVI embolisation (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a captivating collection of featured TAVI cases from PCR London Valves 2024. Witness the management of complex complications such as valve embolization, retrograde migration, and coronary sequestration. Discover innovative percutaneous retrieval techniques, cases of multiple valves in TAVI, and strategies for handling acute valve migration...
Featured Cases - TAVI embolisation (Part 2)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of challenging TAVI cases from PCR London Valves 2024, focusing on the management of TAVI embolization and unexpected events. Learn from real-world experiences on handling transcatheter aortic valve dislodgement, migration, and other complications, and discover innovative techniques for successful bailout strategies.
Featured cases - Paravalvular leak closure
24 Nov 2024 – From PCR London Valves 2024
Dive into a captivating session showcasing selected PCR London Valves 2024 clinical cases on paravalvular leak closure. Witness the use of a hybrid approach for aortic paravalvular leaks, the management of infective endocarditis complications, and the percutaneous treatment of complex malpositioned valves. Explore interventions to address...
The JenaValve Trilogy™ heart valve system in high surgical risk patients with symptomatic, severe aortic regurgitation: The ALIGN AR Trial
25 Oct 2023
Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)